OPEN END TURBO BULL OPTIONSSCHEIN - IPSEN | Delayed Deutsche Boerse AG 10:57:55 15/05/2024 pm IST | ||
| 3.18 EUR | -1.24% |
|
| Current month | +26.27% | ||
| 1 month | +55.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 15/24/15 | 3.18 | -1.24% |
| 14/24/14 | 3.22 | +8.42% |
| 13/24/13 | 2.97 | -2.62% |
| 10/24/10 | 3.05 | 0.00% |
| 09/24/09 | 3.05 | +11.31% |
Delayed Quote Deutsche Boerse AG
Last update May 15, 2024 at 10:57 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
UniCredit
|
| WKN | HC2MMJ |
| ISIN | DE000HC2MMJ5 |
| Date issued | 16/12/2022 |
| Strike | 89.78 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.95 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.63 € |
|---|---|
| Lowest since issue | 1.37 € |
| Spread | 0.22 € |
| Spread % | 6.59% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
121.4
EUR
Average target price
126.3
EUR
Spread / Average Target
+4.07%
- Stock Market
- Certificates
- Certificat
